Brett Brodnax, Director at Lumexa Imaging Holdings, Inc. (LMRI), bought 35,000 shares at $7.25 ($254K) on 2026-05-19, disclosed to the SEC on 2026-05-21.
Director Brett Brodnax purchased 35,000 shares for $253,750 at $7.25, marking the largest insider purchase in Lumexa's history. This move signals confidence in the stock's recovery, particularly given the recent 30-day decline of 11.96%.
The stock is currently trading at $8.205, up 13.88% over the last five days but down 11.96% over the past month. It remains 37.51% below its 52-week high of $13.13 and is trading 27.01% above the 52-week low of $6.46.
Catalysts include the upcoming Q1 2026 earnings reports on May 13-14, 2026, and the fact that this $253,750 purchase represents the largest insider buy in the company's history.
The stock carries a short interest of 12.43% of the float, and Q1 earnings highlighted weather-related disruptions and seasonal volume pressure as headwinds.
Clearly above the average filing.
| Filing → |